Importantly, CD40-stimulated CLL cells were sensitized to death receptor signaling by pevonedistat, which we have shown to be a potent NFκB inhibitor in those cells [15, 16]. The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.